U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H18FN7O2
Molecular Weight 443.4331
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LXE-408

SMILES

CC1=NC(C)=C(O1)C(=O)NC2=CC=C(F)C(=C2)C3=NN4C=C(C=NC4=N3)C5=NC=CC=C5C

InChI

InChIKey=GNVVPYCWVLCWKV-UHFFFAOYSA-N
InChI=1S/C23H18FN7O2/c1-12-5-4-8-25-19(12)15-10-26-23-29-21(30-31(23)11-15)17-9-16(6-7-18(17)24)28-22(32)20-13(2)27-14(3)33-20/h4-11H,1-3H3,(H,28,32)

HIDE SMILES / InChI

Molecular Formula C23H18FN7O2
Molecular Weight 443.4331
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 14:17:05 GMT 2023
Edited
by admin
on Sat Dec 16 14:17:05 GMT 2023
Record UNII
OIK6I0DA01
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LXE-408
Code English
5-OXAZOLECARBOXAMIDE, N-(4-FLUORO-3-(6-(3-METHYL-2-PYRIDINYL)(1,2,4)TRIAZOLO(1,5-A)PYRIMIDIN-2-YL)PHENYL)-2,4-DIMETHYL-
Systematic Name English
LXE408
Code English
Code System Code Type Description
FDA UNII
OIK6I0DA01
Created by admin on Sat Dec 16 14:17:05 GMT 2023 , Edited by admin on Sat Dec 16 14:17:05 GMT 2023
PRIMARY
CAS
1799330-15-6
Created by admin on Sat Dec 16 14:17:05 GMT 2023 , Edited by admin on Sat Dec 16 14:17:05 GMT 2023
PRIMARY
PUBCHEM
118162630
Created by admin on Sat Dec 16 14:17:05 GMT 2023 , Edited by admin on Sat Dec 16 14:17:05 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Dosing at 1 mg/kg b.i.d. led to a 95% reduction of parasite burden in the liver, an efficacy equivalent to that effected by a 12 mg/kg q.d. regimen of miltefosine.
Related Record Type Details
ACTIVE MOIETY